NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $60.25 million. The enterprise value is $147.31 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.80 million shares outstanding. The number of shares has increased by 4.36% in one year.
| Current Share Class | 8.80M |
| Shares Outstanding | 8.80M |
| Shares Change (YoY) | +4.36% |
| Shares Change (QoQ) | +4.18% |
| Owned by Insiders (%) | 8.67% |
| Owned by Institutions (%) | 12.84% |
| Float | 3.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.06 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74
| Current Ratio | 0.74 |
| Quick Ratio | 0.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 39.25% |
| Revenue Per Employee | $920,232 |
| Profits Per Employee | -$185,281 |
| Employee Count | 986 |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NeueHealth has paid $2.05 million in taxes.
| Income Tax | 2.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.01% in the last 52 weeks. The beta is 0.56, so NeueHealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +33.01% |
| 50-Day Moving Average | 6.75 |
| 200-Day Moving Average | 6.20 |
| Relative Strength Index (RSI) | 54.26 |
| Average Volume (20 Days) | 5,678 |
Short Selling Information
The latest short interest is 3,543, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 3,543 |
| Short Previous Month | 4,481 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.09% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, NeueHealth had revenue of $907.35 million and -$182.69 million in losses. Loss per share was -$21.88.
| Revenue | 907.35M |
| Gross Profit | 201.19M |
| Operating Income | -66.08M |
| Pretax Income | -994.38M |
| Net Income | -182.69M |
| EBITDA | -51.44M |
| EBIT | -66.08M |
| Loss Per Share | -$21.88 |
Full Income StatementBalance Sheet
The company has $145.11 million in cash and $225.60 million in debt, giving a net cash position of -$87.50 million or -$9.95 per share.
| Cash & Cash Equivalents | 145.11M |
| Total Debt | 225.60M |
| Net Cash | -87.50M |
| Net Cash Per Share | -$9.95 |
| Equity (Book Value) | -392.97M |
| Book Value Per Share | -153.00 |
| Working Capital | -275.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$95.55 million and capital expenditures -$3.30 million, giving a free cash flow of -$98.84 million.
| Operating Cash Flow | -95.55M |
| Capital Expenditures | -3.30M |
| Free Cash Flow | -98.84M |
| FCF Per Share | -$11.24 |
Full Cash Flow StatementMargins
Gross margin is 22.17%, with operating and profit margins of -7.28% and -14.38%.
| Gross Margin | 22.17% |
| Operating Margin | -7.28% |
| Pretax Margin | -11.81% |
| Profit Margin | -14.38% |
| EBITDA Margin | -5.67% |
| EBIT Margin | -7.28% |
| FCF Margin | n/a |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.36% |
| Shareholder Yield | -4.36% |
| Earnings Yield | -305.42% |
| FCF Yield | -165.25% |
Analyst Forecast
The average price target for NeueHealth is $7.00, which is 2.19% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | 2.19% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0125:1.
| Last Split Date | May 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0125:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |